Talis Biomedical Corporation

OTCPK:TLIS Stock Report

Market Cap: US$3.1m

Talis Biomedical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:TLIS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Sep 24BuyUS$44,240BML Capital Management, LLCCompany30,100US$1.48
03 Sep 24BuyUS$2,000BML Capital Management, LLCCompany500US$4.00
30 Aug 24BuyUS$642BML Capital Management, LLCCompany151US$4.25
28 Aug 24BuyUS$56,137BML Capital Management, LLCCompany14,382US$3.96

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TLIS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies480.00263%
Institutions1900.0104%
Individual Insiders151,5828.32%
Hedge Funds757,02541.5%
General Public913,97550.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 14 shareholders own 49.86% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.9%
Baker Bros. Advisors LP
508,323US$859.1k0%0.01%
13.6%
BML Capital Management, LLC
248,702US$420.3k482%0.2%
6.3%
Randal Scott
114,884US$194.2k0%no data
0.97%
Rustem Ismagilov
17,712US$29.9k0%no data
0.76%
Kimberly Popovits
13,855US$23.4k0%no data
0.23%
Matthew Posard
4,167US$7.0k0%no data
0.037%
Robert Kelley
683US$1.2k0%no data
0.015%
Heinrich Dreismann
274US$463.00%no data
0.0081%
Steward Partners Investment Advisory, LLC
147US$248.30%no data
0.0022%
FBB Associates
40US$67.50%no data
0.0021%
Securities America Advisors, Inc.
38US$64.10%no data
0.00044%
FBB3 LLC
8US$13.60%no data
0.00038%
Melissa Gilliam
7US$11.70%no data
0.00027%
Guggenheim Partners, LLC
5US$8.30%no data